Mid-period crossings: the quarter's story is things that started during it and are still completing
The model's full reasoning — Q3 2018 call → NO我们根据规则分析。关键点是:管理层是否描述了在报告期内或前后真正开始的实际业务活动,并且该活动仍在爬坡中,报告数字低于当前运行水平。 从文字记录看,管理层提到了与Abbott的SurVeil协议,该协议在第二季度签署,但在第三季度确认了1.7百万美元收入。这是否是“开始”?协议在2月(第二季度)宣布,但收入在第三季度开始确认。管理层说“我们与Abbott的合作进展非常好”,并且收入被计为“来自SurVeil协议的1.7百万美元”。这可以视为合同开始产生收入,但它是从第二季度延续的。更关键的是,管理层提到“我们正在更新预期”,并且指引上调。但问题在于是否有一个明确的新业务在期间开始。 另外,管理层提到了Embolitech收购,但那是R&D费用,不是收入开始。还有产品发布如MatrixGuard Diluent,但那是诊断业务,可能不是核心。还有Telemark微导管获得FDA许可,但尚未产生收入?管理层说“正在进行临床评估”,所以还没有销售。还有.014和.018球囊获得许可,但也在评估中。 真正的是不是有“开始”的活动?Abbott协议是第二季度签署,第三季度开始确认收入,但那是“开始”吗?管理层说“第三季度包括1.7百万美元来自SurVeil协议”,并且之前有第二季度确认了部分(可能是0.5百万?)指引上调至4-4.5百万。所以可以说协议的收入在第三季度开始确认,但协议本身在第二季度签署,所以“开始”可能是第二季度。但管理层说“在第三季度我们确认了1.7百万美元”,这属于新收入来源。 但更关键的是,是否有“爬坡”?管理层没有明确说报告数字低于当前运行水平。他们给出了指引上调,但那是由于更好的表现。他们没有说因为活动刚开始所以数字低,而是说整体表现好。 另外,关于BTK和AV程序,他们说“我们现在正在做临床前研究,为首次人体试验做准备”,所以那还不是实际业务开始。 问题要求真正的“开始”活动,并且管理层描述其作为期间故事的核心。这里Abbott协议是核心,但它是从第二季度开始的。而且管理层没有明确说因为部分期间所以低于运行水平。相反,他们说“我们正在更新预期,收入范围上调”,这暗示了更好的表现,但没有说爬坡未完成。 另外,关于Enrollment,他们说“我们正在按计划进行”,但没有说未完成爬坡。 从整个电话看,管理层强调了强劲表现和战略进展,但没有特别指出某个新业务活动在期间内开始且仍在爬坡。Abbott协议是延续,不是新的开始。Embolitech是收购,但那是R&D费用,不是收入。产品发布是未来的事。 因此,我认为答案应为NO。 但让我们再仔细看:管理层说“我们很高兴报告第三季度强劲的运营表现”,并提到Abbott贡献1.7百万,这被视为“开始”了吗?他们之前说“在第二季度宣布协议”,所以开始是第二季度。第三季度是持续确认。所以不符合“期间内开始”。 另外,有没有提到“新工厂开始运营”之类的?没有。 所以答案是NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AIN | Albany International Corp. | Q3 2023 | 2023-11-07 | B |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| HLX | Helix Energy Solutions Group, Inc. | Q1 2018 | 2018-04-24 | B+ |
| SBSI | Southside Bancshares, Inc. | Q4 2017 | 2018-02-06 | A |
| ANIP | ANI Pharmaceuticals, Inc. | Q4 2016 | 2017-03-02 | B+ |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
AFL · Q2 2023 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the Japan Post cancer insurance launch in early April, which began selling the product and drove a 60% sales increase as a major contributor. They describe the activity as real and transacting, with Dan Amos noting the significant contribution from the new product. Yoshizumi confirms gradual increase going forward, and Fred highlights runway for more agents and sales calming down after initial jump, indicating the Q2 numbers reflect partial ramp-up rather than full run-rate.
ESE · Q2 2016 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the real mid-period start of Plastique's contribution (acquired partway through Q2, with two months of performance noted and "early performance consistent with our acquisition forecast"), treated as a key new segment. It also explicitly addresses the incomplete climb, noting that the reported Q 2 numbers lag due to partial contribution and that Q3/Q4 will see fuller periods plus seasonality, with the business already running at a higher level as the ramp continues.
PSX · Q4 2016 → YESThe question is about whether management's account of the just-reported period is built substantially around real business activity that crossed from not-happening to happening partway through the per...YES The transcript shows management centering the Q4 story on the Freeport LPG Export Terminal's real start: commissioning completed smoothly, first commercial cargo shipped mid-December (partial Q4 contribution), with full-quarter costs incurred but only partial revenue, and explicit ramp to near-capacity loading in January onward.